Back to search
FDAFDA · Food and drugs·Recall number D-0463-2024

GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40.

Published May 1, 2024 · Recall initiated: April 19, 2024

Summary

FDA records drug Class II recall D-0463-2024, published May 1, 2024 and initiated April 19, 2024. Recalling firm: Nomax Inc; Status: Ongoing; Reported quantity: 6,960 cartons; Lot: Lot #: 14708, Exp. 04/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

What to do

Voluntary: Firm initiated

Get an email if GLOSTRIPS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GLOSTRIPS
Manufacturer
Nomax Inc
Distributor
Nationwide in the USA
Lot
Lot #: 14708, Exp. 04/30/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40. recalled?

Yes. FDA published recall D-0463-2024 on May 1, 2024. Reported hazard: Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GLOSTRIPS.